Lin Yu-Hsin sold BLTE

September 4, 2026 · Form 4 insider transaction

Lin Yu-Hsin sold 8,111 shares of Belite Bio, Inc at $193.13 per share, a transaction worth $1.57M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Disposed (sell-side)
Shares
8,111
Price
$193.13
Total value
$1.57M
RoleOfficer, Director
SecurityAmerican depositary share
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2026
Filing dateSeptember 9, 2026
Shares owned after96,134
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.; The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/23/2025.; Represents the weighted average price of shares sold at prices that ranged from $193 to $193.33. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR
Lin Yu-Hsin sold BLTE: September 4, 2026 | Insider Trading Screener